The trials are being operated by health practitioners from SEHA who are providing facilities at five of their sites in Abu Dhabi and Al Ain in addition to a mobile clinic to ensure the trials are readily accessible to volunteers participating in the program
The first WHO enlisted global clinical Phase III trial of Sinopharm CNBG’s inactivated vaccine to combat COVID-19 has started in Abu Dhabi and has been inspired by the UAE Leadership’s vision and commitment to overcome the pandemic through a global collaborative effort.
H.E. Sheikh Abdullah bin Mohammed Al Hamed, Chairman of the Department of Health, Abu Dhabi, was the first individual in the world to commence the trial of a Phase III inactivated vaccine for COVID-19. The Department’s Acting Undersecretary, Dr. Jamal Al Kaabi was the second volunteer to trial the vaccine